Analysis of Potential Human Targets and Pathways of Sulforaphane Based on Network Pharmacology

Authors

  • Jiaxin Liu College of Horticulture, Northwest A&F University, Xianyang 712100, China

DOI:

https://doi.org/10.54097/p660qk24

Keywords:

Sulforaphane, Network Pharmacology, Anti-tumor, Anti-inflammatory, Neuroprotective.

Abstract

Sulforaphane (SFN) is a naturally occurring bioactive compound widely present in cruciferous vegetables, and its anti-tumor, anti-inflammatory, and other activities have been extensively studied. This study adopts a network pharmacology approach, aiming to analyze and elucidate the core targets and pathways of SFN across these four pharmacological effects. In this study, relevant targets were first obtained using SwissTargetPrediction and PharmMapper. Subsequently, GO analysis and KEGG enrichment analysis were performed to uncover its action sites in the human body, the functions of the associated target genes, the biological processes involved, and the resulting effects. Further interpretation of the PPI network provides additional insight into its pharmacological actions from the levels of targets and pathways. Based on this, the present paper offers a systematic summary of SFN’s anti-tumor, anti-inflammatory, adjunctive therapy for diabetes, and neuroprotective effects by integrating targets and pathways, and compares these findings with previous studies. In conclusion, sulforaphane, as a promising natural compound with therapeutic and intervention potential in multiple areas, holds promise for contributing to the treatment of related diseases in the future and bringing new hope and prospects to patients undergoing treatment or individuals aiming to prevent these conditions.

Downloads

Download data is not yet available.

References

[1] Ramakrishnan M, Fahey J W, Zimmerman A W, et al. The role of isothiocyanate-rich plants and supplements in neuropsychiatric disorders: a review and update. Frontiers in Nutrition, 2024, 11: 1448130. DOI: 10.3389/fnut.2024.1448130. DOI: https://doi.org/10.3389/fnut.2024.1448130

[2] Benedict A L, Mountney A, Hurtado A, et al. Neuroprotective effects of sulforaphane after contusive spinal cord injury. Journal of Neurotrauma, 2012, 29(16): 2576-2586. DOI: 10.1089/neu.2012.2474. DOI: https://doi.org/10.1089/neu.2012.2474

[3] Daina A, Michielin O, Zoete V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Research, 2019, 47(W1): W357-W364. DOI: 10.1093/nar/gkz382. DOI: https://doi.org/10.1093/nar/gkz382

[4] Daina A, Zoete V. Testing the predictive power of reverse screening to infer drug targets, with the help of machine learning. Communications Chemistry, 2024, 7: 105. DOI: 10.1038/s42004-024-01179-2. DOI: https://doi.org/10.1038/s42004-024-01179-2

[5] Gfeller D, Michielin O, Zoete V. Shaping the interaction landscape of bioactive molecules. Bioinformatics, 2013, 29(23): 3073-3079. DOI: 10.1093/bioinformatics/btt540. DOI: https://doi.org/10.1093/bioinformatics/btt540

[6] Liu X, Ouyang S, Yu B, et al. PharmMapper server: a web server for potential drug target identification via pharmacophore mapping approach. Nucleic Acids Research, 2010, 38(Web Server issue): W609-W614. DOI: https://doi.org/10.1093/nar/gkq300

[7] Wang X, Shen Y, Wang S, et al. Enhancing the enrichment of pharmacophore-based target prediction for the polypharmacological profiles of drugs. Journal of Chemical Information and Modeling, 2016, 56(6): 1175-1183. DOI: https://doi.org/10.1021/acs.jcim.5b00690

[8] Wang X, Pan C, Gong J, et al. PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database. Nucleic Acids Research, 2017, 45(W1): W356-W360. DOI: https://doi.org/10.1093/nar/gkx374

[9] Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nature Communications, 2019, 10(1): 1523. DOI: 10.1038/s41467-019-09234-6. DOI: https://doi.org/10.1038/s41467-019-09234-6

[10] Szklarczyk D, Nastou K, Koutrouli M, et al. The STRING database in 2025: protein networks with directionality of regulation. Nucleic Acids Research, 2025, 53(D1): D730-D737. DOI: 10.1093/nar/gkae1113. DOI: https://doi.org/10.1093/nar/gkae1113

[11] Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research, 2003, 13(11): 2498-2504. DOI: 10.1101/gr.1239303. DOI: https://doi.org/10.1101/gr.1239303

[12] Chen X, Jiang Z, Zhou C, et al. Activation of Nrf2 by sulforaphane inhibits high glucose-induced progression of pancreatic cancer via AMPK-dependent signaling. Cellular Physiology and Biochemistry, 2018, 50(3): 1201-1215. DOI: 10.1159/000494547. DOI: https://doi.org/10.1159/000494547

[13] Medina S, Medrano-Padial C, García-Viguera C, et al. Bioaccessible sulforaphane drives macrophage migration and differentiation by reprogramming the interleukin profile in intestinal inflammation. BioFactors, 2026, 52(2): e70101. DOI: 10.1002/biof.70101. DOI: https://doi.org/10.1002/biof.70101

[14] Miao M A, Zheng N, Yang M. Sulforaphane ameliorates renal injury in diabetic mice through the AMPK/SIRT1/NF-κB signaling pathway. Health Research, 2024, 44(5): 553-557.

[15] Hong Y, Yan W, Chen S, et al. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacologica Sinica, 2010, 31(11): 1421-1430. DOI: 10.1038/aps.2010.101. DOI: https://doi.org/10.1038/aps.2010.101

Downloads

Published

15-11-2026

Issue

Section

Articles

How to Cite

Liu, J. (2026). Analysis of Potential Human Targets and Pathways of Sulforaphane Based on Network Pharmacology. International Journal of Biology and Life Sciences, 17(2), 271-276. https://doi.org/10.54097/p660qk24